Górriz J L, Górriz-Zambrano C, Pallarés-Carratalá V
Servicio de Nefrología, Hospital Clínico Universitario, Valencia. INCLIVA, Universitat de València, Valencia, España.
CAP Sant Pere, ABS Reus 1, Reus, Tarragona, España.
Semergen. 2023 Jun;49 Suppl 1:102021. doi: 10.1016/j.semerg.2023.102021.
Several risk factors may affect the progression of chronic kidney disease (CKD). Arterial hypertension, proteinuria, obesity, intraglomerular hypertension, smoking and metabolic control in diabetes mellitus are the main modifiable risk factors for progression. The progression of CKD involves many cellular processes that originate in specific compartments of the kidney, the vascular compartment with nephroangiosclerosis and the tubulointerstitial compartment with fibrosis and tubulointerstitial atrophy, and there may be overlap between both mechanisms. Given the involvement of so many risk factors and so many pathogenic pathways in the progression of CKD, the best hope for delaying or preventing the progression of CKD lies in a combined and multidisciplinary therapeutic approach, based on the existing evidence and acting on all these processes and pathways from the mechanistic point of view, and on a global process that is cardiovascular and renal risk to improve the prognosis of patients.
几种风险因素可能影响慢性肾脏病(CKD)的进展。动脉高血压、蛋白尿、肥胖、肾小球内高压、吸烟以及糖尿病中的代谢控制是疾病进展的主要可改变风险因素。CKD的进展涉及许多起源于肾脏特定部位的细胞过程,包括伴有肾血管硬化的血管部位以及伴有纤维化和肾小管间质萎缩的肾小管间质部位,并且这两种机制之间可能存在重叠。鉴于CKD进展中涉及如此多的风险因素和致病途径,延迟或预防CKD进展的最大希望在于基于现有证据的综合多学科治疗方法,从机制角度作用于所有这些过程和途径,以及作用于改善患者预后的心血管和肾脏风险这一整体过程。